Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Danielle N. Carr"'
Publikováno v:
Urogynecology. 29:497-503
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3b05a0cd48ddfba5e1571c66c554531
https://doi.org/10.1097/spv.0000000000001301
https://doi.org/10.1097/spv.0000000000001301
Publikováno v:
American Journal of Obstetrics and Gynecology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4c9a8f2c57103aa9f6251f5952315a0
https://doi.org/10.1016/j.ajog.2023.05.024
https://doi.org/10.1016/j.ajog.2023.05.024
Autor:
Danielle N. Carr, Shaina F. Bruce, Joel I. Sorosky, Elizabeth R. Burton, Mark S. Shahin, Mitchell I. Edelson, Mary Naglak
Publikováno v:
Gynecologic Oncology. 149:560-564
Objective Surgical site infections (SSI) are associated with increased morbidity, mortality, and healthcare costs. This study investigated whether implementation of an abdominal closure bundle reduces surgical site infection rates. We aimed to identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f29841b5034d2a973ea68ecd9884a59b
https://doi.org/10.1016/j.ygyno.2018.03.045
https://doi.org/10.1016/j.ygyno.2018.03.045
Autor:
William J. Fulp, John E. Mullinax, Nora Vera, Susan J. Hoover, Christine Laronga, Danielle N. Carr, Geza Acs, M. Catherine Lee, Weihong Sun
Publikováno v:
Cancer Treatment and Research Communications. 9:1-4
Introduction Systemic treatment for second estrogen receptor positive (ER+) invasive breast cancer is controversial. The Recurrence Score (RS) from the 21-gene breast cancer assay (ODX) is used for adjuvant therapy recommendations in primary, early-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f6942a5cdbc57a50e9ab169acbc7247
https://doi.org/10.1016/j.ctarc.2016.06.004
https://doi.org/10.1016/j.ctarc.2016.06.004
Autor:
Marie Catherine Lee, William J. Fulp, Weihong Sun, Christine Laronga, Danielle N. Carr, Susan J. Hoover, Nora Vera, Geza Acs
Publikováno v:
Journal of Surgical Research. 198:27-33
Adjuvant treatment for early stage, estrogen receptor (ER) positive invasive breast cancer has been based on prognosticators such as menopausal status. The recurrence score (RS) from the 21-gene assay Oncotype DX (ODX) is predictive of a 10-y distant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ebc2b8307cf2bced220d4099643a3a7
https://doi.org/10.1016/j.jss.2015.05.034
https://doi.org/10.1016/j.jss.2015.05.034